Buske C - Search Results

1

High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature.

Herold T, Mulaw MA, Jurinovic V, Seiler T, Metzeler KH, Dufour A, Schneider S, Kakadia PM, Spiekermann K, Mansmann U, Hiddemann W, Buske C, Dreyling M, Bohlander SK. Herold T, et al. Among authors: buske c. Leuk Lymphoma. 2013 Aug;54(8):1652-7. doi: 10.3109/10428194.2012.753445. Epub 2012 Dec 27. Leuk Lymphoma. 2013. PMID: 23189934

2

Proliferation of human leukemic pre-B cells induced by human bone marrow stromal cells and murine fibroblasts.

Buske C, Hiddemann W, Wörmann B. Buske C, et al. Cell Biol Int. 1994 Nov;18(11):1049-58. doi: 10.1006/cbir.1994.1028. Cell Biol Int. 1994. PMID: 7894389

3

TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors.

Buske C, Becker D, Feuring-Buske M, Hannig H, Wulf G, Schäfer C, Hiddemann W, Wörmann B. Buske C, et al. Leukemia. 1997 Mar;11(3):386-92. doi: 10.1038/sj.leu.2400586. Leukemia. 1997. PMID: 9067578

4

Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.

Buske C, Gogowski G, Schreiber K, Rave-Fränk M, Hiddemann W, Wörmann B. Buske C, et al. Exp Hematol. 1997 Apr;25(4):329-37. Exp Hematol. 1997. PMID: 9131008

5

Human herpesvirus-8 (HHV-8) DNA associated with anaplastic large cell lymphoma of the B-cell type in an HIV-1-positive patient.

Buske C, Hannig H, Hiddemann W, Bodemer W. Buske C, et al. Int J Cancer. 1997 Oct 9;73(2):303-4. doi: 10.1002/(sici)1097-0215(19971009)73:2<303::aid-ijc23>3.0.co;2-e. Int J Cancer. 1997. PMID: 9335459 No abstract available.

6

Treatment of follicular follicle centre lymphomas: current status and future perspectives.

Hiddemann W, Unterhalt M, Buske C, Sack H. Hiddemann W, et al. Among authors: buske c. J Intern Med Suppl. 1997;740:55-62. J Intern Med Suppl. 1997. PMID: 9350184 Review.

7

In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand.

Buske C, Twiling A, Gogowski G, Schreiber K, Feuring-Buske M, Wulf GG, Hiddemann W, Wörmann B. Buske C, et al. Leukemia. 1997 Nov;11(11):1862-7. doi: 10.1038/sj.leu.2400822. Leukemia. 1997. PMID: 9369419

8

[Systemic therapy of low malignancy non-Hodgkin lymphomas].

Wörmann B, Buske C, Hiddemann W. Wörmann B, et al. Among authors: buske c. Praxis (Bern 1994). 1998 Jun 3;87(23):806-11. Praxis (Bern 1994). 1998. PMID: 9654987 Review. German.

9

TGF-beta and its receptor complex in leukemic B-cell precursors.

Buske C, Becker D, Feuring-Buske M, Hannig H, Griesinger F, Hiddemann W, Wörmann B. Buske C, et al. Exp Hematol. 1998 Nov;26(12):1155-61. Exp Hematol. 1998. PMID: 9808055

10

Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission.

Feuring-Buske M, Haase D, Buske C, Hiddemann W, Wörmann B. Feuring-Buske M, et al. Among authors: buske c. Leukemia. 1999 Mar;13(3):386-92. doi: 10.1038/sj.leu.2401300. Leukemia. 1999. PMID: 10086729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters